Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer

ConclusionsOur study provides preclinical in vitro and in vivo evidence of the effectiveness of PEGylated liposomal doxorubicin as a  radiosensitizer, supporting its potential clinical development as a component of chemoradiotherapy.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research